# Tolerance & Responsiveness Improvement for Metformin (TRIM)

> **NCT03670043** · PHASE4 · COMPLETED · sponsor: **West Side Institute for Science and Education** · enrollment: 29 (actual)

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DRUG:** Psyllium powder
- **DRUG:** Metformin Extended Release Oral Tablet

## Key facts

- **NCT ID:** NCT03670043
- **Lead sponsor:** West Side Institute for Science and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-19
- **Primary completion:** 2020-10-15
- **Final completion:** 2021-08-15
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03670043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03670043, "Tolerance & Responsiveness Improvement for Metformin (TRIM)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03670043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*